BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 15661929)

  • 1. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.
    Qiao SW; Piper J; Haraldsen G; Oynebråten I; Fleckenstein B; Molberg O; Khosla C; Sollid LM
    J Immunol; 2005 Feb; 174(3):1657-63. PubMed ID: 15661929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopes.
    Dørum S; Arntzen MØ; Qiao SW; Holm A; Koehler CJ; Thiede B; Sollid LM; Fleckenstein B
    PLoS One; 2010 Nov; 5(11):e14056. PubMed ID: 21124911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
    Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
    J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
    Skovbjerg H; Koch C; Anthonsen D; Sjöström H
    Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase.
    Arentz-Hansen H; Körner R; Molberg O; Quarsten H; Vader W; Kooy YM; Lundin KE; Koning F; Roepstorff P; Sollid LM; McAdam SN
    J Exp Med; 2000 Feb; 191(4):603-12. PubMed ID: 10684852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen presentation to celiac lesion-derived T cells of a 33-mer gliadin peptide naturally formed by gastrointestinal digestion.
    Qiao SW; Bergseng E; Molberg Ø; Xia J; Fleckenstein B; Khosla C; Sollid LM
    J Immunol; 2004 Aug; 173(3):1757-62. PubMed ID: 15265905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
    Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
    Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions.
    Stamnaes J; Fleckenstein B; Sollid LM
    Biochim Biophys Acta; 2008 Nov; 1784(11):1804-11. PubMed ID: 18793760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl
    Engstrom N; Saenz-Méndez P; Scheers J; Scheers N
    Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
    Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
    Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
    Rauhavirta T; Hietikko M; Salmi T; Lindfors K
    Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.
    Rauhavirta T; Oittinen M; Kivistö R; Männistö PT; Garcia-Horsman JA; Wang Z; Griffin M; Mäki M; Kaukinen K; Lindfors K
    J Clin Immunol; 2013 Jan; 33(1):134-42. PubMed ID: 22878839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 in celiac disease: minireview article.
    Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
    Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sourdough fermentation of wheat flour does not prevent the interaction of transglutaminase 2 with α2-gliadin or gluten.
    Engström N; Sandberg AS; Scheers N
    Nutrients; 2015 Mar; 7(4):2134-44. PubMed ID: 25816160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.
    Shan L; Qiao SW; Arentz-Hansen H; Molberg Ø; Gray GM; Sollid LM; Khosla C
    J Proteome Res; 2005; 4(5):1732-41. PubMed ID: 16212427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease.
    Huan J; Meza-Romero R; Mooney JL; Vandenbark AA; Offner H; Burrows GG
    Mucosal Immunol; 2011 Jan; 4(1):112-20. PubMed ID: 20736999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar Responses of Intestinal T Cells From Untreated Children and Adults With Celiac Disease to Deamidated Gluten Epitopes.
    Ráki M; Dahal-Koirala S; Yu H; Korponay-Szabó IR; Gyimesi J; Castillejo G; Jahnsen J; Qiao SW; Sollid LM
    Gastroenterology; 2017 Sep; 153(3):787-798.e4. PubMed ID: 28535873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
    Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.